Health Catalyst, Inc. - Common Stock, par value $0.001 per share (HCAT)

Historical Holders from Q3 2019 to Q3 2025

Symbol
HCAT on Nasdaq
Type / Class
Equity / Common Stock, par value $0.001 per share
Shares outstanding
70.9M
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
54.1M
Holdings value
$154M
% of all portfolios
0.001%
Grand Portfolio weight change
0%
Number of holders
141
Number of buys
72
Number of sells
-72
Average Value change %
+0%
Average buys %
+0%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Health Catalyst, Inc. - Common Stock, par value $0.001 per share (HCAT)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
First Light Asset Management, LLC 19.68% -0.35% $41.2M -$138K 13.9M -0.33% Mathew P. Arens 01 Dec 2025
BlackRock, Inc. 6.3% $17.5M 4.41M BlackRock, Inc. 31 Mar 2025
VANGUARD GROUP INC 5.88% $16.4M 4.13M The Vanguard Group 31 Mar 2025
Stoney Lonesome HF LP 5.5% $11.5M 3.9M COGHILL CLINT D 15 Dec 2025
Whetstone Capital Advisors, LLC 5.4% $10.6M 3.73M Whetstone Capital Advisors, LLC 30 Jun 2025

Institutional Holders of Health Catalyst, Inc. - Common Stock, par value $0.001 per share (HCAT)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 54.1M $154M -$4.6M $2.85 141
2025 Q2 54.2M $204M +$2.03M $3.77 144
2025 Q1 53.2M $241M -$15.1M $4.53 163
2024 Q4 51.7M $366M +$10.7M $7.07 164
2024 Q3 52M $423M +$11.7M $8.14 158
2024 Q2 51M $326M +$3.63M $6.39 159
2024 Q1 50.1M $377M +$765K $7.53 170
2023 Q4 49.7M $460M +$1.6M $9.26 165
2023 Q3 49.4M $500M +$2.97M $10.12 155
2023 Q2 48.8M $610M +$4.1M $12.50 152
2023 Q1 48.5M $566M -$1.97M $11.67 158
2022 Q4 48.8M $519M -$2.73M $10.63 164
2022 Q3 49M $476M -$73.2M $9.70 163
2022 Q2 52.9M $767M -$46.9M $14.49 170
2022 Q1 53.3M $1.39B -$65.4M $26.13 180
2021 Q4 55.2M $2.19B +$48.2M $39.62 178
2021 Q3 53.3M $2.67B +$252M $50.01 198
2021 Q2 48.1M $2.67B +$253M $55.51 197
2021 Q1 43.9M $2.05B +$163M $46.77 187
2020 Q4 40.4M $1.76B +$87.9M $43.53 168
2020 Q3 40M $1.46B +$230M $36.60 138
2020 Q2 34M $991M +$213M $29.17 127
2020 Q1 27.1M $708M +$93.4M $26.15 107
2019 Q4 23.4M $811M +$30.4M $34.70 87
2019 Q3 16.7M $523M +$523M $31.64 85